Charity registrdtion number 1181623 BRITISH SOCIETY OF ENDOVASCULAR THERAPY ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS FOR Ycmrs ciYucD 31 JANUAR T 2ti24 Gibbons f i riccountants & Tax Advisers SOLUTIONS SERVICE
BRITISH SOCIETY OF ENDOVASCULAR THERAPY LEGAL AND ADMINISTRATIVE INFORMATION Trust8es Professor B Modar Mr S Neeouaye Mr P Bevis Mr P MoxF7 MrAbarattis Ms E Wkon Mr M CJaThlge Ms B Sandford Dr K Lewi5 Dr S Dindyal IAprx)uited 30 June 20231 IW'-,ted 30 Jur.e 20231 IAptX)T'nted 30 June 20231 30 June 20231 MT N Datt8ni M%s K Swith ¢harlty number 1181623 Independent examiner Gibbons Carleton Hous8 IAbrknngton Curnbria CA142LU
BRITISH SOCIETY OF ENDOVASCULAR THERAPY CONTENTS Pag8 Trustees. )rt Independert ex¥rnineVs report StstenRN OT knntsai ami 8aJ8rKe sheet Notes to the finanual staternents 8-13
BRITISH SOCIETY OF ENDOVASCULAR THERAPY TRUSTEES. REPORT rOR THE YEAR ENDED 31 JANUAR Y 2024 The trustee5 present annual report and fmanual statements for Ihe year ended 31 January W24. The financial statements have been PTapared In arAan1 tkn the ac)untsn9 po11ie$ set out in note 1 to the financial statements and compty with the rth8rity's govemrng doCAJ¢nI. Ihe Charibe5 Act 2011 and 'Accounting and Reporting by Charities.. Staternent of Recornmended Pracbce apDlic8ble to charits.es DreD8ring Iheir accounts in accordanc£ 1h the FInanU Reporbn9 siandard appknbk itie UK -_d RepknV4I v. ,,.-,,. leffedive 1 January 20191. Oblectlves and actrvths The British Society of Endiwas¢yJL4rTherapYs prirnary r(Ae is to prormte the best in rÈ888rth, training. educab.on and dinical practice of endovas¢ular therapies for Ihe benefft of people medthl Cor1.0$ who could be potenttalty helped by endowasojtar Iherapies. It athieves this wilh the fouowng 8iir6: to advance neatth by prorrb)ting scienlik researd). edUL¥ and training in end85JL8T treathnt and procedu$,. and to 8ffvance the educalion of Ihe publi and arwryJ5t heamh professionals ITh endovaslar treatment and procedures The Society continues its cxjmmitmenl to irnprwng the qu¥ of endovas(JJlar surgery in the UK through its trasning course5, Annual Meeting and Train9 FeUowEhips. The 88ET rrEeting is the only dediGqied UK meeting for the presentsb.on of endovasujtsr Search. lis unique format encourages high level dk%tsJ5SSDn a¥ partiopation and the ffleeting faculty attracts the worfd's leading endovascular spe(Jalists. The Souety'$ tru$tees have Mpld wilh the duty in Section 4 of the Charili&s Ad 2011 to have due regard to Publi¢ Benefft guidance publi%hed by the Charity Commission. A¢hlevemerrts and perfoance n and Trainin The Soaety'sAnnual Meeting wa$ hek1 In JU 2023. The rneeting aitracted over 120 endovascular consuttants, trainee5 and zllie(5 medir21 professionals_ The programme ts)mpri$ed presentations frorn guest speaker8 from Italy. Denmark and the Nether18nds, vAth abstract and poster pfesentsts.ons from endova5cular trainees M the A N8tional Vascular TraIng Day was held prior to Ihe Annual Meeting for jynior endovaswlar trainees ¢omprf$ing srnall case based disDJssion group8 and pra¢b"ral train9 on endova5¢ulai devi. The BSET Endovascular Training Course was held Tn 2023 for senior vascular 8n(S interventional radiology tr8ineès. Attendees were taught in small group sesssons looknng 81 the finer points of endovascular treatment alongside sndusty who provk1ed h8ndn pracal trning on 5UFgical dewce5. The BSET Fellowship Programme w8s advertised for 2023 and one End0¥asL1[ Training Fellowship was appointed vtho undertook a six trdining post at St Georges Hosortal. London. Two Endovascular Travel Felw5 were appointed. and ftmding was gNen to $4wt frjrther traMing in sperAaknst endovascular unts In Denmark and NorthAmenca.
BRITISH SOCIETY OF ENDOVASCULAR THERAPY TRUSTEES. REPORT (CONTINUED) FOR THE YEAR ENDED 31 JANUARY2024 Researth The BSET-ConfomiabLe ÈndoVas¢UT Aneurysm Registy. on behf of Gore. comrnen¢ed in 2019. The primary objectwe of the giStry is to eolw 3wortd dini(21 data and de specific othu)rres of GORE EXCLUDER Confom)able AAA Endopr05the515 in rotrtine dinical treatsnent of abdominal aoTb¢ alleurysm. All (lat3 check5 On 12 monlh fojlow-up dinical %Jata has been anawd. A manusrript has been ppared for publ¢ion to the European Joumal of V8soJlar anc Endovascular otsrgery (EivLaj. I nere are various reguiaTW proceoures required for study clostrout. Sndudlng a fjnal report to the Nat)nal Eilics Commrttee recording the siuty resuh5 in Clinicarrrials.gov. Progrès$ was n¥gde wEth Ihe GLOBALSTAR projecr during Ihe year. A ¥a5(yJlar searcher based at a speuali5t unit commen(d WO in following up Ihe lone dats from Contribting rttres. 807 ¢ases tt) o)mpiete p operative data had been identified in seven 'historic' centsES, with four addstional ntreS co[¥buting dats. The dats would be presented at the Annual Meeting in June 2024. The proj&t colle¢is dutability data on fenestrated devices wth one of the lonpsl followpS in Ihe literatsJr& 11 is Ihat publith.on ot the final data wli I po$rtivety Inffluence cotrvrussioning deosion5wilhin the NFIS. Struclur8 vem ce mèna The forrral Trustee m8etiros were hdd person and LTh orth duriThJ Ihis wic4. Organisabonal m81ters were dealt with wa email. A new PresthnL Toasuw and Education Committee Chaw5 wer8 &tted in June 2023. and four nav Trustees. A complaint5 policy was produced whith would be made avali ab on request. The Trustees ha¥e adcnowtedged the need for a poll¢y on equality. diver5tty and indusion. This has been the subied of discussion at Trustee meetings and an appropriate polLy be tJWished in due o)urse. Aims and kev ob 8chves forfufu riods The Trustees planned to wntinue to hold the EndovasrJJL4r Training cou8 In ma 2024, and also holo the Annual Meeting and National VaSl8r Trainry Day in June 2024. as fa¢e4othce nting$. An EndovaScurTrair9 Fell(ShIp Travel Fellowship be offered in 2024. A Researrt+ Pump PriftHng Grant be awarded kn $UPFrt a resea proieci in the field of endovascular therapy. The Trustees wll cortin to Y)tk dwrity The CiriyJ8tion Foundation to update their patient inlormatk)n leaflets relating to endovasculartreatment. Discus$ions I11 take ptace with the Biibsh Society of Iterventional R8diokn with Ihe aim to form a doser lation5hip beeen BSET and 8SIR to Invo inaSed partK>pab"on of Sooety men*Jers at both rneetings and in¢aSed dologue.
BRITISH SOCIETh OF ENDOVASCULAR THERAPY TRUSTEES. REPORT (CONTINUED) FOR THE YEAR ENDED 31 JANUARY 2024 Financial review The Society's reserves vras in(xeased to £280.L¥X) to refiect cost oflmng inc¥ea58s. Thi5 WOU alow 8SET to keep oppwmatety 2 yèars 8nnual operating costs in resei¥e. The bslee5 will conlifjue to asse55 the level of reserves il requires and will UBle the poliw rf rt 15 fe its finanoal rffjvlMents have changed. Tiie reserve$ kX)Ilry ensu$ Un$b)C ftmds are sufficient to nwttsvo year5, actsvity ofthe Sodety, to cover. al The rtsk of unforeseen errrgency or othw unexpe¢W need for lunds. e.g. io provide'seed-funding, for an urgent project. bl Unforese8n daY-tdaY opwational costs. e.g. empbw.ng terwrary slaff to rknver a kJThJ48rrn sick absence. CIA source ofincorrE. e.g. a spon50tship of tsjr Mee"n9$. not bw.ng nrtd. Fund$ mttt be needed to giv8 the trustees time to take ad¥)n rfincoffe W$ Wow ewtation8. d) The need to fiJnd short4etm deficits wi a cash bud9eL e.g. mney need to Èe spent before a fijnding grant is received. stTUCtur81 governance and managem8nt Every trustee is 8pwnled for a terrn of three years. In selecing indMdu for appointment as rtharty tnJste8S, the charity trustees must have ward lo the skills, knedge and experience neeiSed tsrthe effeLtive adTh¢nistration of the CIO. IndDriduals 8r8 requested to Submit a 21)) lwrd pelsonal statement I101 why they wtsh to act as a th8tEty tFUStee. I new trustees a asked to s1Jn a stslement Ofell7 a sentthe folk)w4ng.' . The ¢hariVs con$blui The minutes of Counul rneetings forthe w2vKJus year, st of Current Irustee$ and ¢onts¢.t det¥il¢: Annual list of dates of trustee rneetings- The most recent Charty ac¢(wnts". . Acopy ofthe Cha¢ty Cim¥sston put4ication Tr Essential Trustee- lthat you ne8d to kr¥)vl.. The Trustees agreed to vtsoduce a new role ofV&Presldeftt The Wr&PresKlent will commence the role after Ihe Annual Meeting in June 2ff24 for a one year lead4n period p[lt0 taking on the le as President for two years trom June 2025. The p05thon be Op to all pwous and Current Counal mernkn2rs of 8SET. There are fourtru5tee (COUry rneetings a yearatwhth operati and finan(aal matters of the a discussed, anl slr8tegi¢ de¢i$i¢ns about the direction of the th8rity are taken. In been meetings. deasons are made by telephone or e-rnail communK3tson belween the Honorary Qfters and olhertrustees. An adrninistratorwcthg on a mn5ultrdry basis deats *7th lthe tnalters pertainrng to the gener organlsatton of the Society. Annual Meeting and oU)erevents. BSET has collabotiVe links With Ihe Royal Cdlege ot Sut9eons (Engl. Royal College of Sur9eon5 IEdl, the Vaswlar Souety of Goal Britaip and Ireland. Ihe Rouleaux Club. the Britsh Society of Interventional Radiology, the BSIR Trairtses to help fvrther the aims of the devekjping sp8L¥ality an¢J to ddwer high standard5 of practice. The trustees, rep rt was appro¥ed ty the Board of Ttustee& -$or B Modarnl Trustee Dotecj..
BRITISH SOCIETY OF ENDOVASCULAR THERAPY INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF BRITISH SOCIETY OF ENDOVASCULAR THERAPY I report to the trustees on my examination of the financial statements of Britssh Society Of Endovascular Therapy Ilhe charity) for the year ended 31 January 2024. Responsibilities and basls of report As the trustees of the charity you are responsible for the preparation of the financial statemenls in accordanee with the requirements of the CharitiesAct 2011 Ilhe 2011 Acll. l port in respecl of my examination of the charity's finaal slaternerts canied out under seclion 145 of the 2011 Act. carrying out my examination I have followed als the applicable Direth"ons given by the Charity Commission under section 145{5llbl of the 2011 Act. Independent exarninerfs statement Since the charity's gross income exceeded £250.000 your examiner musl be a member of a body listed in section 145 of the 2011 Act. l Confirm that l am qualffied to undertake the examination because l am a member of ICAEW, which is one of the listed bcdies. Your attention is drawn to the fact that the charity has ppared financial statements in accOrdae with Accounting and Reporting by Charrties preparing their accounts in ardance with the Financial Reporting Standard applicable in the UK and Republic of Ireland IFRS 1021 in preference to the Accounting and Reporting by Charits"es". Ststement of Recommended Practice issued on 1 April 2005 vthich is referred to in the exianl regulations but has now been wrthdrawn. l understand that this has been done in order for financial statements to provide a true and fair view in accordance with Generally Accepted Accounting Practice effective for reporting periods beginning on or after 1 January 2015. I have completed my examinab"on. I confimi that no matters have come to my attention in connection wrth the examination giving me cause to believe that in any material respect". accounting records were not kept in respect of the tharity as required by section 130 of the 2011 Act,. or the financial ststements do not accord wth those records", or the financsal statements do not comply Trmth the appli(3ble requirements conceming the fomi and content of accounts sel out in the Charrties (Account5 and Reports) Regulatsons 2008 other than any requirement that the accounts give a true and fair view which is not a matter o)nsidered as part of an independent examinalion. I have no concems and have come across no other matters in connection Trmth the examination to which attention should be drawn in this report in order to enable a woper understanding of the finarla1 statements to be reached. Tony Hindmoor BFP FCA Gibbons Carfeton House 136 Gray Street Workington Cumbria CA14 2LU Dated.. 03 July 2024
BRITISH SOCIETY OF ENDOVASCULAR THERAPY STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT FOR THE YEAR ENDED 31 JANUARY2024 Current linanci81 year Unrestricted Restricted funds funds 2024 2024 Tota5 Total 2024 2Q3 Notss eande Donation$ and legathes Other trading a¢bvib"e5 Other Inco 18.976 204,999 29.207 2,844 26.299 26.299 Totsl income 68,964 389.907 253,182 end•Te on.. Charitable activities 234.81kl 76.003 310.809 228.769 Net in¢omellexpendlturel for the yrf Net movement In funsJ$ 86.337 17.0391 79,298 24,413 Fund balances at q Febwary 2023 287.7G3 72.470 360,233 335.820 Fund balances at31 January 2024 374,1(N) 65,431 439.531 3eo,233 The statement of hancial acti¥71ies indudes all gains and 1055es recognised in the year. The statement of finandal a¢tNitss indudes all 98ins and kjsses reuyjntsed in the yw. All ir¢¢ome and expenditure derive from continwng activibes.
BRITISH SOCIETY OF ENDOVASCULAR THERAPY STATEMENT OF FINANCIAL ACTIVITIES (CONTINUED) INCLUDING INCOME AND EXPENDITURE ACCOUNT FOR THE YEAR ENDED 31 JANUARY2024 Prforfinanclal year Unrestrlcted Reskncted funds funds 2023 2023 Total 2Q23 Income and endoWer from: Donations and legaue$ Othertrading activ¥ts Other income 18.976 18,976 204.999 204.999 29.207 Total Incorne 234.206 18.976 253.182 nditure on: Charitable actvities 228,769 228.769 Net incomall8xp8ndituro1 for the yearl Net movement in fund5 5.437 18.976 24,413 Fund balances at 1 February 2022 282,326 335.820 Fund balances 4131 January 2023 287,7&3 72,470 360.233 The statement of fir$an¢y a¢bvlbes tyudes al gains bsse5 reCognd in the ye&. The statement of finanL?al xbvibes tndudes al gains and losses rwi58d in the year. income and expenditure delive from COnnuing a(ths.
BRITISH SOCIETY OF ENDOVASCULAR THERAPY BALANCE SHEET AS AT 31 JANUARY2024 2023 Fixed a$$ets Investments 10 1(X),100 Current asstrts Cash at bank and ffl hand 340.&51 1,763 Credltors: amounts falling due wlthln one year 11 11,520) {1.5301 Net currarrt a88ets 339.431 360.233 Total assets less current liabi1sbeS 439,531 380.233 The funds of the ¢harlty Restricted intt>me fitnds Unrestrrcted funds 12 65.431 374.100 287.763 439,531 360,233 The fwRn(aal statements were approved by the tW8tees on ....................... Mr P Bevis Trustee
BRITISH SOCIETY OF ENDOVASCULAR THERAPY NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 JANUARY2024 A¢¢ountlng pollel8S Charity infom1aon Brth"sh Society Of ErtdovasCUbrThe is a dwritabk incarFwaW orgar¢Lsatson. 1.1 Accounting convention The finanual statemerFts have been prepare(l in ar£Orda wdh the Charibe$ Act 2011 and 'Acc04Jnlillg and Reporting by Charities." StsteryETht of Rea)rnrnptMled Pracbce ap.Cable to charity.es preparing their accounts in accordance with the FinaficM?l Reptyb"ng Stsndar<l appCab in the UK and Republic of Ireland IFRS 1021 leffedve 1 January 20191". The charity va a Benefft Entity 8$ defined by FRS 102. The Charity has tsken advantsge of the pro¥isiortS in the SORP for tharfties apthng FRS 102 Update Bulletin I not to prepa a Ststement of Cash Fhw5. The finanoal Statements have departed from the Charities IAco)uftts and Rewrt51 Regusations 2008 onty to the extent required lo provide a tsue and fair wew. Thi5 deparbJre has Involv following the Statement o Recomrnended Practtce for tharits.es apptying FRS 102 rather than the ve15ion of the Statem8nt o Recommenijed Pra¢ttts whKh is referred to in the Regulations but which ha$ been wthdrawn. The finarrial statements are ppare¢l in sreding, whith is the fiJnctienal currency of the charity. Monetary amounts in these fin8Yal 5talernents are rounded to the nearesi£. The financ2{ stateFr%nts have been pwared under the hi8tori¢al cost ¢orNentson. The PrinGipal accounting policies adow 8re sel out bthw. 1.2 Going concem At the time of approv19 the fin[la1 state, Ihe trustees have a reasonable expectation that the ¢h8rity has adequate resources to continue in operabDnal e$ten for the fore5e8able fijttjre. Thus the trustees conb.nue to adopt the gorng concern bas5 of accounting in preparin9 the frnanoal statements. 1.3 Charitable fund8 Unrestricted fvnds are avadable for use at Ihe tscrth)n of ltte trustees in lurther8nce of thei¥ th8rit8ble objeVe8. Reslricted funds are subject to speufic CondOn$ by donor$ 01 9ranlots as lo how they may be used. The purposes and uses of the rethL#ed fvnds are set out Ihe notes to the finanoal statements. Endovm)ent funds are 8ubJ'erA to SP condthns by donors that Ihs captial must b8 maintained by Ihe charty. 1.4 Income Incorne is regnISed wn the ¢hanty 15 legalty entttled to it after ary performance coftditbns have been rn8L Ihe amounts Can be rneasured reliabty. and it is probable that ino)me wll be received. Cash dollations afe retn1$e0 on recerpt. other donations are Tecognrsed once the chanty has been notified of the ¢Jonats"on. unless rf0mlanes conditions requi éeferral of the arnounl. Income tax re¢overable in relatKJn to donation5 [eceW ufider IAll or dls ol covenant is recognised at the ts'¥ne of the donation. Legaoe5 are rècognised on receipt or ¢Xherwse rf the charity has been notsfied of an impending distribubon, the amount ts known. and receipt is experJed_ If the arrK)unt is not known. the lègacy is treated a$ a ctsntingent ¥et
BRITISH SOCIETY OF ENDOVASCULAR THERAPY NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 JANUAR Y2024 Accountlng pollcies l¢ontinuedl Expenditure is recognised ono there is a legal or conslwciwe ¢]blwJation to trdnsfei econotnic benefit to a thir¢ paty. it Is probable that a transfer tsf eCorn¢ beneffts be required in sett18rnent, the amount of the obtlgalfon can be measu lIablY. ExpendttLSre is ¢ksSrfd Lry athity. The costs of e acbvty are Hde up of the total of direct costs and shared costs, induding support costs in¥oW in uftdertakiryj eath acbyfy. Direct ¢05ts attributabje to a $in9le adiwty are alliKed directy to that actNity. Shafed costs which contribute to more than one activty and support cost5 which are not attributable to a single actmty a apporboned beiween thDse actiwties on a basis eonsistent wrth the use of resources. Central staff costs are 8Kor2ted the basis of b"nE spent. and depreciaUon ¢harges a¥e alloL3ted on the of the a5sefs use. 1.$ Fixed asset invesknents Fn%ed asset investmerts are Thasur8d at transaction price exduding tran$aclton Ix)sts. and are subsequenty MeaSud at fwr value at each reporting date. Change5 in fair value are rognis8 in net i£0e1(eXpn1tuTe} forthe year. Transaction costs are expensed as incurred. 1.6 Cash and cash equlvalents Cash and esh equN2lents in(th cash h hand. deposits Ij at ¢all with banks, other short4erm INuid invements ith original rnaturtbes of three mon1hs or188s. and bank overdrafts. Bank overdrafts are sh¢Mn thin borrowings in current Irdbilths. B•$l¢ Ilnancial assets BasiG financial assets, Ythich indude debtors and cAsh and bank bakn¢es. a inity.alty 3Sred at transaction priee in¢furfing transauion costs and are 5ubwuentty L¥rried at arrK)rbsed cost using the effective Interest method unless the arrangement constrtutes a finanrang transadion. vJhÈre the ton5a¢tion is rn88sured at the psent value ol the future receipts discounted al a market tate of interest. Finanaal assets dassified as Ce1v8b within one year are not arntiftised. Bèsic financial fiabilili8s Ba$iG firTrancial labilities, induding creditors and bank loans are in"alty recogfirsed at transaclitsn price unless the arrangement eonslttutes a ffinanong transadion, where the debt 1nsthJmt is measured ai the present value ol the future payments diso)unted at a nwrket rate of teSt. Financial IrabileS classified as payable thin one year are not arnortised. Debt instruments are subsequently ced at amrtised o)st. using the effethe Ulte$1 rate ¥tEthod. Trade creditors a oblKJation$ to pay for go(MJs or servKes that have been acquired in the ordin8ry course of opeotions frorn supplier5. Amounts payable are dassifred as current liabilth.es rf payment is due wthin one year or less. If not. they are presented as fjon-cuellt IbIlitieS. Trade Lyeditors ar8 recA)gnise¢ initplly al transa¢tN)n ptice and subsequenty measured at amorti&ed cost using the effecbve interest rnethod. DeognItIon of financial lialItieS Financial liabilthes a dere(w¥M5ed kn the tharity's contracbjal obfigations expire or are discharged or anlled.
BRITISH SOCIETY OF ENDOVASCULAR THERAPY NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 JANUARY2024 ¢rftlcal accounting •stimat•s and JUdgwents In the applicaton of the charity's acwjnting policS, the trustees are requi1 to rnake judgernents. estimates and assumph.ons aboirt the onying anThinl of assets and tsbll ¢bes that are not 8lty app8nt from other $our¢e$. The esbtnates and a5$0csated assump)"ons are based on historical eXperfen and othertsrAors that are considered to be retevant. Actual results may differ frorn estirnates. The estimates and undetyng a$$umpl"ons are reweM*d on an onwing basis. Revtsion$ to 8CCOUlltkig estimates are recogni5ed in the period in whth the estirnate 15 rew5ed where the revision affect5 onty that period. or in the pwiod of the revLwn aThl fvlure periods where tt)e levisn alfects both current and future periods. Donallons and Iw¢ies Restrtcted Re$Mctsd nds funds 2024 2023 CLEVAR incorne 18,976 Income from othertradsng activrbos Unrestricted Unresthctsd funds fund8 2024 2023 nual meeting regLthYon Sponsorships 42,279 162.720 256.000 Other trading 8CtNibes 294.644 204,999 Other Income Unrestricted Unrestricled funds fund$ 2024 2023 Other income Spring courses income 1.704 24.595 373 28,834 26.299 29,207 io-
BRITISH SOCIETY OF ENDOVASCULAR THERAPY NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 JANUARY2024 Charltable actlvltles Tolal 2024 Total 2023 Annu81 meeung costs SuTrdry expenses Tiavel and 5ubsi5tan( Spring course exPerrture Accountancy fees Con5uttancy fees Bank charges Postage, printing and ststioTWy PrFzes and bursaries CLEVAR expenditure Fellowship 105.837 3.271 142,026 4,101 976 24,241 2.113 28.359 133 19,8(X) 201 470 75,498 54,481 35,LYJO 310.609 228.769 310.&)9 228,769 Anaty818 by lund UnRslricted hjnds Reskncted funds 234.606 76.003 228,769 310.809 228.769 None of the trustee5 lor any p8150ns con[ th8ml re¢ev1 atry remuneth.on or benefits from the charity during the year. Employees The average monthty nrnr oferr¥k)w dulu Ihe year was.. 2024 Number 2023 Number Total There were no employees vthose anttual rEtwnewatiDn VAS rnorE than £80.c. Taxation The charty i5 exerryDI from tsx on sncc4ne and gain$ tslling wilhin 5PCtion 505 of the Taxes Act 1988 or $ectK)n 252 of the TaxatK)n of Chaffjeable Gains Act 1992 to the exient that Ihese are appl lo it5 charitab18 obiects.
BRITISH SOCIETY OF ENDOVASCULAR THEFIAPY NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 JANUAR Y 2024 10 Flxed a1 investments Unlist8d investments ¢o$t orvaluation At 1 February 2023 Adon$ 100,100 At 31 January 2024 100,100 CarryiNJ amount At 31 January 2024 100,100 At 31 January 2023 11 Creditors". amounts fallbi9 dLJe withln one year 2024 2023 Ae£ruals and defeired Sncome 1.530 1.530 12 Re$ts1¢ted fvnds The restricted funds of Ihe chanty coryrise the uftexpeftiled balances of donats.ons and grants held on Irust subjeLt to spectfic condibons by as to how they msy be used. Movernenl In funds Iy¢(MThng 8•lJnc• It IncornN Resources ourres 1 Febwuwy reEoufc25 expended 23 A%)v8ment in funds 8¥ln¢& ai l Fbrvary 2•2Z Balance at 31 January 2024 BSET CLEVAR Gbbalstar 18.976 24.270 48.2Q) 175.4981 15051 17.738 47,695 48.2 18.976 72.470 e8.964 (76,003) 65.431 12_
BRITISH SOCIETY OF ENDOVASCULAR THERAPY NOTES TO THE FINANCIAL STATEMENTS IcoKllNUED) FOR THE YEAR ENDED 31 JANUARY2024 13 Unrestrfcted lunds The UnstriL*ed fur5 ofthe tharity mpriSe Ihe unexpeftded balances of donation$ and grants whth ar8 not Subject to specffjc condibons by donors and gr8rrtors as to how they be used. These indude denated lunds which have been set as1 OLrt of unrestrrAed fvnds ty IhetswÈes for spe¢ffi¢ purposes. At 1 Febnry Incomlny Resources At 31 January 2023 resourus expended 2024 Gene funds 287.7&3 320.943 1234.6C61 374,100 Prevlous year. At 1 F¢bnry Incorning Resources At 31 January 2022 resoue$ expended 2023 Gener31 fvnds 282.328 234.21 [228.7691 287.763 14 Analy9 of net assets between fvnds UnrT5tricted Restricted funds nds 2024 Totsl Unresbicted Restricted fvnds nds 2023 2023 2024 2023 Fund balances 8t 31 January 2024 aT& represented by.. lTrveslrnents Current asseWOi¥bditiesl 14J).1 274.1 100.1 339.431 65.431 287.763 72,470 360,233 374.11x1 .431 439.531 287.763 T2.470 360.233 15 Related party transa¢tÉons There re no di8closabie ielatsd party transadion5 duiing the year P023- nor). 13_